The Global Platelet Rich Plasma (PRP) Market is set to grow on account of increase in the occurrence of orthopedic and sports injuries. Key insights have been shared by Fortune Business Insights in its report, titled “Platelet Rich Plasma Market Size, Share And Global Trend By Origin (Allogeneic, Autologous, Homologous), By Type (Pure PRP, Leukocyte rich PRP, Leukocyte rich fibrin), By Application (Orthopaedic surgery, Cosmetic surgery, General surgery, Neurosurgery, Others), And Geography Forecast Till 2026”.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Adistem Ltd
- DePuy Synthes Companies
- Isto Biologics
- Cesca Therapeutics Inc.
- Nuo Therapeutics, Inc.
- Stryker Sage
North America to Make the Largest Contribution to the Market
The global platelet rich plasma market to rise on the shoulders of North America as the region is slated to hold the top position in terms of market share in the forecast period. High prevalence of sports injuries and orthopaedic surgeries coupled with high demand for cosmetic treatments are the factors that are expected to drive the market. In terms of CAGR, Asia-Pacific, primarily India and China, are anticipated to widen the market base. Main reasons identified for Asia-Pacific are the rising percentage of the population having rheumatology disorders. Added to this is the increasing demand of cosmetic surgeries and growing instances of sports injuries.
The reports analyses the different factors influencing the growth of this market during the forecast period. Plasma is a part of blood that contains proteins that help in clotting of blood and support cell growth. Platelet-rich plasma is a substance that is injected into the body to accelerate healing. The basic idea is to stimulate the body to grow new and healthy cells by injecting the platelet-rich plasma into it. Cases where platelet-rich plasma injections are used include hair growth, tendon injuries, osteoarthritis, and post-surgical repair. It has also been applied to reduce inflammation and promote tissue healing.
Quality and Cost Issues Hampering the Rise of the Market
While the global platelet rich plasma market is on the threshold of experiencing rapid growth, it has to overcome certain hurdles. These are mainly in the form of high costs platelet-rich plasma therapies and poor quality control of test results. Moreover, the US Food and Drug Administration has not yet approved of the platelet-rich plasma treatments. Such hindrances are hampering the smooth rise of the global platelet rich plasma market.
- Pure PRP
- Leukocyte rich PRP
- Leukocyte rich fibrin
- Orthopaedic surgery
- Cosmetic surgery
- General surgery
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
More Trending Topics From Fortune Business [email protected]